TG Therapeutics, Inc.
TGTX
$35.63
-$0.38-1.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.31% | 501.31% | -43.60% | 164.25% | 25.73% |
| Total Depreciation and Amortization | -11.11% | -18.18% | -42.11% | -34.48% | -23.68% |
| Total Amortization of Deferred Charges | -1.12% | -23.77% | -32.51% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 26.34% | -25.29% | 77.24% | 9.75% | -7.99% |
| Change in Net Operating Assets | 20.08% | -90.86% | -198.41% | -75.79% | 24.64% |
| Cash from Operations | -11.99% | -110.09% | -320.47% | 167.45% | 37.87% |
| Capital Expenditure | -19.05% | 12.50% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -181.66% | 269.81% | -627.48% | 119.07% | 79.32% |
| Cash from Investing | -181.92% | 269.15% | -628.84% | 119.07% | 79.32% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -96.32% | 186.43% | 47.41% | 1,250.00% | -- |
| Repurchase of Common Stock | 7.38% | -207.63% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 96.39% | -- | -- | -- |
| Cash from Financing | -0.49% | -104.52% | 99,495.56% | 1,250.00% | 1,100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.85% | -114.10% | 1,418.49% | 142.61% | 69.89% |